Spiro compounds as modulators of muscarinic receptors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S212020, C514S255050, C540S543000, C544S230000, C544S238000, C544S278000, C544S358000, C546S017000

Reexamination Certificate

active

07858635

ABSTRACT:
The present invention relates to spiro compounds of formula XX as modulators of muscarinic receptors, wherein R1, R2, R3, Z1, Z2, L, G, n, m, t and p are defined herein. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

REFERENCES:
patent: 3654287 (1972-04-01), Dykstra
patent: 3666764 (1972-05-01), Campbell et al.
patent: 3959475 (1976-05-01), Bauer et al.
patent: 3962259 (1976-06-01), Bauer et al.
patent: 4233307 (1980-11-01), Ono et al.
patent: 4349549 (1982-09-01), Roszkowski et al.
patent: 4558049 (1985-12-01), Bernardi et al.
patent: 5091387 (1992-02-01), Evans et al.
patent: 5219860 (1993-06-01), Chambers et al.
patent: 5536716 (1996-07-01), Chen et al.
patent: 5576321 (1996-11-01), Krushinski et al.
patent: 5578593 (1996-11-01), Chen et al.
patent: 5614523 (1997-03-01), Audia et al.
patent: 5627196 (1997-05-01), Audia et al.
patent: 5652235 (1997-07-01), Chen et al.
patent: 5658921 (1997-08-01), Perregaard et al.
patent: 5741789 (1998-04-01), Hibschman et al.
patent: 5789402 (1998-08-01), Audia et al.
patent: 5817679 (1998-10-01), Shen et al.
patent: 5885999 (1999-03-01), Elliott et al.
patent: 6013652 (2000-01-01), Maccoss et al.
patent: 6130217 (2000-10-01), Arnold et al.
patent: 6166040 (2000-12-01), Fairhurst et al.
patent: 6326375 (2001-12-01), Fukami
patent: 6436962 (2002-08-01), Hoffman et al.
patent: 6566367 (2003-05-01), Bakthavatchalam et al.
patent: 6720324 (2004-04-01), Marzabadi et al.
patent: 6828440 (2004-12-01), Goehring et al.
patent: 6869960 (2005-03-01), Ito et al.
patent: 6943199 (2005-09-01), deLombaert et al.
patent: 7045527 (2006-05-01), Chen et al.
patent: 7205417 (2007-04-01), Fukami et al.
patent: 7279471 (2007-10-01), Mueller et al.
patent: 7351706 (2008-04-01), Bissantz et al.
patent: 2002/0188124 (2002-12-01), Fukami et al.
patent: 2003/0036652 (2003-02-01), Bakthavatchalam et al.
patent: 2003/0158219 (2003-08-01), Ito et al.
patent: 2004/0054177 (2004-03-01), Otake et al.
patent: 2004/0072847 (2004-04-01), Bakthavatchalam et al.
patent: 2004/0122074 (2004-06-01), Dow et al.
patent: 2004/0142956 (2004-07-01), Chen et al.
patent: 2004/0204397 (2004-10-01), Chaturvedula et al.
patent: 2005/0033048 (2005-02-01), Bakthavatchalam et al.
patent: 2005/0143372 (2005-06-01), Ghosh et al.
patent: 2005/0153998 (2005-07-01), Ito et al.
patent: 2005/0176703 (2005-08-01), Gabriel et al.
patent: 2005/0215576 (2005-09-01), Degnan et al.
patent: 2005/0261332 (2005-11-01), Distefano et al.
patent: 2006/0019962 (2006-01-01), Makings et al.
patent: 2006/0040964 (2006-02-01), Bakthavatchalam et al.
patent: 2006/0106045 (2006-05-01), Huges et al.
patent: 2006/0111380 (2006-05-01), Otake et al.
patent: 2006/0173027 (2006-08-01), Marzabadi et al.
patent: 2006/0183904 (2006-08-01), Guo et al.
patent: 2006/0211722 (2006-09-01), Jiao et al.
patent: 2006/0217372 (2006-09-01), Blanco-Pillado et al.
patent: 2007/0043023 (2007-02-01), Makings et al.
patent: 2007/0254903 (2007-11-01), Boatman et al.
patent: 1535967 (2004-10-01), None
patent: 2444728 (1975-04-01), None
patent: 3342164 (1984-05-01), None
patent: 0065864 (1982-12-01), None
patent: 0070171 (1983-01-01), None
patent: 0128886 (1984-12-01), None
patent: 0414289 (1991-02-01), None
patent: 0444945 (1991-09-01), None
patent: 0445974 (1991-09-01), None
patent: 0486280 (1992-05-01), None
patent: 0518805 (1992-12-01), None
patent: 0533243 (1993-03-01), None
patent: 0615977 (1994-09-01), None
patent: 0722941 (1997-11-01), None
patent: 1 415 986 (2004-05-01), None
patent: 1575800 (1980-10-01), None
patent: 2131021 (1984-06-01), None
patent: 2308064 (1997-06-01), None
patent: 2355264 (2001-04-01), None
patent: 2355456 (2001-04-01), None
patent: 59059685 (1984-04-01), None
patent: 2001/278886 (2001-10-01), None
patent: 2002/316987 (2002-10-01), None
patent: WO 94/19367 (1994-09-01), None
patent: WO 94/22846 (1994-10-01), None
patent: WO 95/09631 (1995-04-01), None
patent: WO 95/11029 (1995-04-01), None
patent: WO 95/14025 (1995-05-01), None
patent: WO 95/28389 (1995-10-01), None
patent: WO 97/41878 (1997-11-01), None
patent: WO 97/41879 (1997-11-01), None
patent: WO 99/06434 (1999-02-01), None
patent: WO 99/09984 (1999-03-01), None
patent: WO 99/32489 (1999-07-01), None
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/06146 (2000-02-01), None
patent: WO 00/06153 (2000-02-01), None
patent: WO 00/06545 (2000-02-01), None
patent: WO 00/38720 (2000-07-01), None
patent: WO 01/02386 (2001-01-01), None
patent: WO 01/22919 (2001-04-01), None
patent: WO 01/29027 (2001-04-01), None
patent: WO 01/45707 (2001-06-01), None
patent: WO 01/64213 (2001-09-01), None
patent: WO 02/48152 (2002-06-01), None
patent: WO 02/070511 (2002-09-01), None
patent: WO 02/085354 (2002-10-01), None
patent: WO 02/094825 (2002-11-01), None
patent: WO 03/014083 (2003-02-01), None
patent: WO 03/064425 (2003-08-01), None
patent: WO 03/095427 (2003-11-01), None
patent: WO 03/106457 (2003-12-01), None
patent: WO 2004/004714 (2004-01-01), None
patent: WO 2004/010942 (2004-02-01), None
patent: WO 2004/010943 (2004-02-01), None
patent: WO 2004/011427 (2004-02-01), None
patent: WO 2004/028459 (2004-04-01), None
patent: WO 2004/050652 (2004-06-01), None
patent: WO 2004/074273 (2004-09-01), None
patent: WO 2004/089307 (2004-10-01), None
patent: WO 2005/016913 (2005-02-01), None
patent: WO 2005/063254 (2005-07-01), None
patent: WO 2005/063745 (2005-07-01), None
patent: WO 2006/001958 (2006-01-01), None
patent: WO-2006/023852 (2006-03-01), None
patent: WO 2006/058303 (2006-03-01), None
patent: WO 2006/058303 (2006-06-01), None
Bignan et al, “Preparation of 3-spirocyclic indolin-2-ones as ligands for the ORL-1 receptor”, Bioorganic & Medicinal Chemistry Letters 15 (2005) 5022-5026.
Chambers, Mark S. , et al., “Spiropiperidines as high-affinity, selective σ ligands,” Journal of Medicinal Chemistry (1992), 35(11), 2033-9.
Dhar, T.G. Murali, “Design and synthesis of novel αla adrenoceptor-selective antagonists,” Journal of Medicinal Chemistry (1999), 42 (23), 4778-4793.
Efange, S.M.N., et al., “Spirovesamicols: Conformationally restricted analogs of 2-(4-Phenylpiperidino) cyclohexanol (Vesamicol, AH5183) as potential modulators of presynaptic cholinergic function,” Journal of Medicinal Chemistry (1994), 37 (16), 2574-82.
Efange, Simon, et al, “Vesamicol analogs as sigma ligands. Molecular determinants of selectivity at the vesamicol,” Biochem. Pharm. (1995), 49(6), 791-7.
Efange, S.M.N., et al., “Comparative tissue distribution of conformationally restricted radioiodinated vesamicol receptor ligands,” Nuclear Medicine and Biology (1995), 22(4), 437-44.
Efange, Simon M.N., et al.; “N-Hydroxyalkyl Derivatives of 3β-Phenyltropane and Methylspiro[1H-indoline-3,4′-piperidine]: Vesamicol Analogues with Affinity or Monoamine Transporters,” J. Med. Chem. (1997) vol. 40, pp. 3905-3914.
Evans, Ben E. , et al., “Orally active, nonpeptide oxytocin antagonists,” Journal of Medicinal Chemistry (1992) 35(21), 3919-3927.
Moltzen, Ejner K., et al., “σ Ligands with Subnanomolar affinity and preference for the σ2 binding site,” Journal of Medicinal Chemistry (1995), 38(11), 2009-17.
Yang, Lihu, et al., “Potent 3-spiropiperidine growth hormone secretagogues,” Bioorganic & Medicinal Chemistry Letters (1998), 8(1), 107-112.
Yang, Lihu, et al., “The design and synthesis o fnon-peptide somatostatin receptor agonists,” Peptides for the New Millennium, Proceedings of the American Peptide Symposium, 16th, Minneapolis, MN, Jun. 26-Jul. 1, 1999 (2000), Meeting Date 1999, 250-252.
International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2005/029780, filed Aug. 19, 2005. Forms PCT/ISA/210 & PCT/ISA/237.
Partial International Search from the European Patent Office issued in a corresponding PCT application PCT/US2005/029780 with I

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Spiro compounds as modulators of muscarinic receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro compounds as modulators of muscarinic receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro compounds as modulators of muscarinic receptors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4153881

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.